Evidence map›Paper›PMID 40707891›Full record

ArticleBMC infectious diseases2025

Isolation and characterization of bacteriophages with lytic activity against multidrug-resistant non-typhoidal Salmonella from Nairobi City county, Kenya.

Michael Mugo, Abednego Musyoki, Angela Makumi, Ivy Mutai, Kelvin Kering, Peter Muturi, Collins Kebenei, Kristin Weber, Michael Pietsch, Tanja Pilz and 6 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michael MugoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya. mikemugom@gmail.com.
Abednego MusyokiDepartment of Medical Laboratory Science, Kenyatta University, Nairobi, Kenya.
Angela MakumiInternational Livestock Research Institute (ILRI), Nairobi, Kenya.
Ivy MutaiSchool of Veterinary Medicine & Sciences, University of Nottingham, Sutton Bonington Campus, Nottingham, UK.
Kelvin KeringCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Peter MuturiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Collins KebeneiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kristin WeberDivision of Enteropathogenic Bacteria and Legionella (FG11), Robert Koch Institute, Wernigerode, Germany.
Michael PietschDivision of Enteropathogenic Bacteria and Legionella (FG11), Robert Koch Institute, Wernigerode, Germany.
Tanja PilzGenome Competence Centre (MF1), Robert Koch Institute, Berlin, Germany.
Oliver DrechselGenome Competence Centre (MF1), Robert Koch Institute, Berlin, Germany.
Tobias HoffmannAdvanced Light and Electron Microscopy (ZBS 4), Robert Koch Institute, Berlin, Germany.
Lothar WielerHasso-Plattner-Institute, Digital Global Public Health, Potsdam, DE, Germany.
Cecilia MbaeCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Antje FliegerDivision of Enteropathogenic Bacteria and Legionella (FG11), Robert Koch Institute, Wernigerode, Germany.
Samuel KariukiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya. skariuki@kemri.go.ke.

Funding

Deutsche Forschungsgemeinschaft FL 359/9-1Deutsche Forschungsgemeinschaft Wl 1436/13-1
6 · The paper itself

Abstract

backgroundNon-typhoidal Salmonella (NTS) typically cause self-limiting enterocolitis, but can lead to life-threatening invasive diseases, particularly in sub-Saharan Africa. In Kenya, multidrug-resistant (MDR) NTS strains with increasing non-susceptibility to third-generation cephalosporins pose a growing public health threat. As traditional antimicrobial treatments become less effective, bacteriophages are emerging as a potential alternative. This study aimed to isolate and characterize bacteriophages targeting MDR and extended spectrum-β-lactamase (ESBL)-producing non-typhoidal Salmonella (NTS).

methodsEnvironmental samples were collected from seven sites in Nairobi City County, Kenya. Four NTS bacterial strains were used for phage enrichment, screening, and purification via spot tests and plaque assays. Phage efficacy was assessed in vitro by testing host range and efficiency of plating (EOP) against 12 Salmonella strains isolated in Kenya over different years. Ten selected broad-host-range phages were evaluated for thermal and pH stability and their ability to disrupt pre-formed NTS biofilms. Phage genomes were sequenced using the Illumina sequencing platform, and analyzed with bioinformatics tools to screen for antimicrobial resistance (AMR), lysogeny, virulence, and allergenic genes. The morphological characteristics of four representative phages were examined using Transmission Electron Microscopy.

resultsThirty-one phages were isolated, with host ranges varying from lysing one strains to all 12 strains. Ten phages lysed more than 80% of the Salmonella strains and were selected for further characterization. Most phages exhibited high production EOP on at least one bacterial strain, except KE26 and KE28. All phages were stable from - 80 °C to 40 °C and pH 5 to 11, with noticeable but statistically insignificant biofilm disruption. Genome sizes ranged from 23,215 bp to 159,981 bp, and were free of known AMR, lysogeny, or virulence genes. Allergenicity screening identified no allergenic hits across most phages, with exception of KE23, which showed potential allergenic regions in its tail fiber and endolysin proteins. All phages belonged to class Caudoviricetes, with KE23, KE26, and KE28 exhibiting a myovirus-like morphotype, and KE15 displaying a siphovirus morphotype.

conclusionThis study identified phages with desirable safety and stability profiles for potential usage against MDR and ESBL-producing NTS infections. Further in vivo studies are recommended to evaluate their therapeutic potential. IMPORTANCE: Non-typhoidal Salmonella (NTS) typically cause self-limiting enterocolitis but can lead to life-threatening invasive diseases. In Kenya, multidrug-resistant (MDR) NTS strains with increasing nonsusceptibility to third-generation cephalosporins have been reported, posing a significant public health concern that requires urgent attention. Bacteriophages are increasingly being considered as an alternative treatment for MDR bacterial infections because of the growing ineffectiveness of conventional antibiotics. Our study reports the isolation and characterization of lytic Salmonella phages devoid of detectable antimicrobial resistance (AMR) genes, lysogeny potential, allergens or virulence factors. These attributes position them as promising candidates for therapeutic interventions against MDR NTS infections. These findings highlight the potential of our study phages as a therapy for drug-resistant NTS and underscore the need for further investigation into their clinical application against MDR strains.

Indexed as

BacteriophagesDrug Resistance, Multiple, BacterialSalmonellaSalmonella PhagesGenome, ViralHost SpecificityHumansKenyaSalmonella InfectionsAnd phageMultidrug-resistantNon-typhoidal Salmonella

Identifiers

PMID40707891
PMCPMC12291259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.